IMUGENE LIMITED (IMU)



Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today Ľ it's FREE! Already a member? Login now!


General Information
Company Name: Imugene Limited
Stock Code: IMU
Website: www.imugene.com
GICS Sub-Industry: Biotechnology
Market Cap ($M): 11
Equiv. Shares (M): 878

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.012 $ 0.000 $ 0.000 $ 0.000 $ 0.012 0 0%

Current Broker Consensus Recommendation more
Recommendation: Sell
Recommendation Date: 19th Dec 2008
12 Month Target Price (average): $0
Brokers Surveyed: 1

Company Overview

Business Description:
Imugene Limited (IMU) is an Australian pharmaceutical company with a drug delivery platform at the centre of its assets known as Linguet. IMU currently focuses on consumer healthcare products and Vitamin D therapeutics.


Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2013  A -1.6 -0.5 -- 0.0 0.0 0.0 --
2012  A -1.0 -0.7 -333.3 0.0 0.0 0.0 --
2011  A 0.4 0.3 -- 19.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2011 A 2012 F 2013 F 2011 A 2012 F 2013 F 2011 A 2012 F 2013 F
CSL (CSL) $32,769 M 0.3878 -0.0521 0.1274 25.9367 27.3627 24.2716 0.0162 0.0154 0.0176
Imugene (IMU) $10 M -- -- -- -- -- -- 0.0000 -- --
Mesoblast (MSB) $1,551 M -- -- -- -- -- -- 0.0000 0.0000 0.0000
Starpharma (SPL) $212 M -- -- -- -- -- 11.9775 0.0000 0.0000 0.0000
Sirtex Medical (SRX) $876 M 0.0596 0.3669 0.3208 48.7813 35.6882 27.0209 0.0000 0.0091 0.0114

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
IMU -- -- 2.40 -- --
Market 1.23 13.9 0.96 1.03 3.13
Sector 0.65 18.8 3.95 1.53 9.42

Directors
Name Position Start Date
Dr Nicholas Ede Executive Director 11 February 2013
Mr Paul Hopper Non-Executive Director 31 October 2012
Dr Axel Hoos Non-Executive Director 20 December 2013

Management
Name Position
Justyn Stedwell Company Secretary
Phillip Hains Joint Company Secretary

Substantial Shareholders
Holding Name
25,000,000 (6.61%) Consegna Group Ltd
18,900,000 (5.00%) Tisia Nominees Pty Ltd <Henderson Family A/C>

Calendar of Events
Date Event
26 February 2015 Report (Interim)
26 September 2014 Report (Annual)
28 August 2014 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Investing and Trading in US Shares

An educational booklet that shows how to use international share trading to diversify your investments.

More details...

News

Billionaires bankroll Ten's new direction Media Network sees digital future

The Age 19/12/2013 | Ten Network's programming ambitions will be funded by a $200 million loan guaranteed by three of its billionaire owners, as the free-to-air broadcaster declared digital was the future and pointed to early signs that its switch to an older market demographic was working.

Elders alleges $24m fraud in live cattle division

The Age 19/12/2013 | Troubled rural services group Elders is threatening to call in the police over an alleged $24 million fraud by a "handful of individuals" in its live cattle exports division.

Bega Cheese holds back in three-way bidding war for WCB

The Age 19/12/2013 | Bega Cheese began the battle for Warrnambool Cheese & Butter but three months on it appears to be the first casualty of the bidding war.

Aussie hampers transition

The Age 19/12/2013 | A persistently high Australian dollar is thwarting the Reserve Bank's efforts to ease the transition of the economy away from mining.

RBA keeps its focus on lower dollar

The Age 19/12/2013 | The Reserve Bank is keeping the door open to further interest rate cuts, but believes the "significant amount" of monetary policy easing over the past two years is already stimulating growth.

Pact's struggles weigh down Orora

The Age 19/12/2013 | The underwhelming sharemarket debut of packaging company Pact Group Holdings has weighed on the demerger of Amcor and its $2 billion Australasian packaging and distribution business Orora.

More...


Sponsored Links

Feedback Form